Sigma Healthcare : Change of Director's Interest Notice

Appendix 3Y

Change of Director's Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	SIGMA HEALTHCARE LIMITED
ABN	15 088 417 403

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Mark Robert Hooper
Date of last notice	27/03/2019

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest	N/A
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Date of change	13/09/2019
	19/09/2019
	20/09/2019
No. of securities held prior to change	38,830,284
	Ordinary Shares	12,734,355
	Shares allocated pursuant
	to the employee share plan	56,112
	Shares allocated pursuant to
	the loan funded long term
	incentive plan	23,161,315
	Performance rights granted
	pursuant to the long term
	incentive plan	2,878,502

• See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1

Appendix 3Y

Change of Director's Interest Notice

Class	Ordinary
Number acquired	7,500
Number disposed	4,543,034
Value/Consideration	$3,025,196.80 value of shares disposed
Note: If consideration is non-cash, provide details and estimated	$5,025.00 value of share acquired
valuation
No. of securities held after change	34,294750
	Ordinary Shares	15,039,613
	Shares allocated pursuant
	to the employee share plan	63,612
	Shares allocated pursuant to
	the loan funded long term
	incentive plan	16,313,023
	Performance rights granted
	pursuant to the long term
	incentive plan	2,878,502
Nature of change	4,543,034 ordinary shares sold on market
Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan, participation in	6,848,292 shares pursuant to the 2014
buy-back
	loan funded long term incentive plan
	converted to ordinary shares.
	7,500 shares allocated pursuant to the
	employee share plan

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract

N/A

Nature of interest

Name of registered holder (if issued securities)

Date of change

+ See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y

Change of Director's Interest Notice

No. and class of securities to which interest related prior to change

Note: Details are only required for a contract in relation to which the interest has changed

Interest acquired

Interest disposed

Value/Consideration

Note: If consideration is non-cash, provide details and an estimated valuation

Interest after change

Part 3 - +Closed period

Were the interests in the securities or contracts No detailed above traded during a +closed period where prior written clearance was required?

If so, was prior written clearance provided to allow the trade to proceed during this period?

If prior written clearance was provided, on what date was this provided?

• See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 3